Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (TXG)
NASDAQ:TXG
10x Genomics (TXG) Stock Price & Analysis
627 Followers
TXG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.81 - $58.30
Previous Close$55.19
Volume1.86M
Average Volume (3M)900.42K
Market Cap
$6.39B
Enterprise Value$6.07B
Total Cash (Recent Filing)$420.79M
Total Debt (Recent Filing)$102.04M
Price to Earnings (P/E)-36.2
Beta2.40
Next Earnings
Aug 02, 2023EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding116,192,123
10 Day Avg. Volume1,034,969
30 Day Avg. Volume900,425
Standard Deviation0.16
R-Squared0.37
Alpha-0.00215
Financial Highlights & Ratios
Price to Book (P/B)8.19
Price to Sales (P/S)37.73
Price to Cash Flow (P/CF)-384.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.32
Enterprise Value/Gross Profit15.33
Enterprise Value/Ebitda-42.62
Forecast
1Y Price Target
$64.63Price Target Upside17.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
10x Genomics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TXG FAQ
What was 10x Genomics Inc’s price range in the past 12 months?
10x Genomics Inc lowest stock price was $23.81 and its highest was $58.30 in the past 12 months.
What is 10x Genomics Inc’s market cap?
Currently, no data Available
When is 10x Genomics Inc’s upcoming earnings report date?
10x Genomics Inc’s upcoming earnings report date is Aug 02, 2023 which is in 56 days.
How were 10x Genomics Inc’s earnings last quarter?
10x Genomics Inc released its earnings results on May 03, 2023. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.375 by -$0.065.
Is 10x Genomics Inc overvalued?
According to Wall Street analysts 10x Genomics Inc’s price is currently Undervalued.
Does 10x Genomics Inc pay dividends?
10x Genomics Inc does not currently pay dividends.
What is 10x Genomics Inc’s EPS estimate?
10x Genomics Inc’s EPS estimate is -$0.4.
How many shares outstanding does 10x Genomics Inc have?
10x Genomics Inc has 98,124,870 shares outstanding.
What happened to 10x Genomics Inc’s price movement after its last earnings report?
10x Genomics Inc reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.375. Following the earnings report the stock price went up 1.296%.
Which hedge fund is a major shareholder of 10x Genomics Inc?
Among the largest hedge funds holding 10x Genomics Inc’s share is ARK Investment Management LLC. It holds 10x Genomics Inc’s shares valued at 232M.
---
10x Genomics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$64.63 (17.10% Upside)
$64.63 (17.10% Upside)
Blogger Sentiment
Neutral
TXG Sentiment 50%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 604.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $355.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.72%
12-Months-Change
Fundamentals
Return on Equity
-21.67%
Trailing 12-Months
Asset Growth
1.07%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
10x Genomics Inc
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.
---
Top 5 ETFs holding TXG
ARK Genomic Revolution ETF
$39.83M
iShares Biotechnology ETF
$34.39M
iShares Russell Mid-Cap Growth ETF
$15.48M
iShares Russell 1000 Growth ETF
$14.48M
Vanguard Health Care ETF
$14.02M
Up to five ETFs with an Outperform Smart Score that hold TXG. The ETFs are listed according to market value of TXG within the ETF
---
---